Voyager Therapeutics (VYGR) Shares Outstanding (Diluted Average) (2019 - 2026)
Voyager Therapeutics' (VYGR) quarterly Shares Outstanding (Diluted Average) came in at $59.5 million in Q1 2026, up 1.96% year-on-year from $58.3 million in Q1 2025, and up 1.18% quarter-over-quarter from $58.8 million in Q3 2025.
Voyager Therapeutics (VYGR) Shares Outstanding (Diluted Average) (2019 - 2026) Analysis & Trends
Voyager Therapeutics has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $59.5 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 810.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 92.44 Mn |
| 10 | Voyager Therapeutics | 222.52 Mn | 81.04 Mn | - | 59.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.50 Mn |
| Sep 30, 2025 | 58.80 Mn |
| Jun 30, 2025 | 58.51 Mn |
| Mar 31, 2025 | 58.35 Mn |
| Sep 30, 2024 | 57.85 Mn |
| Jun 30, 2024 | 57.42 Mn |
| Mar 31, 2024 | 57.12 Mn |
| Jun 30, 2022 | 38.30 Mn |
| Mar 31, 2022 | 38.05 Mn |
| Jun 30, 2021 | 37.54 Mn |
| Mar 31, 2021 | 37.50 Mn |
| Jun 30, 2020 | 37.03 Mn |
| Jun 30, 2019 | 34.99 Mn |